# EDGAR Filing Document

**Accession Number:** 0000731012
**File Stem:** 0000731012-25-000097
**Filing Date:** 2025-7
**Character Count:** 22828
**Document Hash:** cbfe2ed42c2b5c302a15547b986b8fb3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000731012-25-000097.hdr.sgml**: 20250723

**ACCESSION NUMBER**: 0000731012-25-000097

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250723

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250723

**DATE AS OF CHANGE**: 20250723

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEALTHCARE SERVICES GROUP INC
- **CENTRAL INDEX KEY:** 0000731012
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-NURSING & PERSONAL CARE FACILITIES [8050]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 232018365
- **STATE OF INCORPORATION:** PA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-12015
- **FILM NUMBER:** 251141608

**BUSINESS ADDRESS:**
- **STREET 1:** 3220 TILLMAN DRIVE
- **STREET 2:** SUITE 300
- **CITY:** BENSALEM
- **STATE:** PA
- **ZIP:** 19020
- **BUSINESS PHONE:** 2159381661

**MAIL ADDRESS:**
- **STREET 1:** 3220 TILLMAN DRIVE
- **STREET 2:** SUITE 300
- **CITY:** BENSALEM
- **STATE:** PA
- **ZIP:** 19020

?xml version='1.0' encoding='ASCII'? hcsg-20250723

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

**FORM 8-K**

**CURRENT REPORT**

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 23, 2025

**<u>HEALTHCARE SERVICES GROUP, INC.</u>**

(Exact name of registrant as specified in its charter)

Commission File Number: 0-12015

<u>Pennsylvania</u> <u>23-2018365</u> <br> (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification number)

<u>3220 Tillman Drive, Suite 300, Bensalem, Pennsylvania</u>

(Address of principal executive office)

<u>19020</u>

(Zip Code)

Registrant's telephone number, including area code: 215-639-4274

&nbsp;&nbsp;&nbsp;&nbsp;

<u>Not Applicable</u>

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

(☐)&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

(☐)&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

(☐)&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

(☐)&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.01 par value | HCSG | NASDAQ Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

------

<u>Item 2.02</u> Results of Operations and Financial Condition.

On July 23, 2025, Healthcare Services Group, Inc. (the "Company") issued a press release (the "Press Release") announcing its earnings for the three months ended June 30, 2025. A copy of the Press Release is being furnished hereto as Exhibit 99.1 and is hereby incorporated by reference to this Current Report.

The information furnished herein, including Exhibit 99.1 shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

<u>Item 9.01</u> Financial Statements and Exhibits.

(a)&nbsp;&nbsp;&nbsp;&nbsp;Not applicable

(b)&nbsp;&nbsp;&nbsp;&nbsp;Not applicable

(c)&nbsp;&nbsp;&nbsp;&nbsp;Not applicable

(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.

---

| | |
|:---|:---|
| Exhibit Number | Description |
| 99.1 | <u>[Press Release and financial tables dated](ex99-2025xq2xpressrelease.htm)[July](ex99-2025xq2xpressrelease.htm)[23, 2025, issued by Healthcare Services Group, Inc.](ex99-2025xq2xpressrelease.htm)</u> |
| 104 | Cover page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | <u>HEALTHCARE SERVICES GROUP, INC.</u> |
| Date: July 23, 2025 | By: | /s/ Vikas Singh |
|  |  | Name: Vikas Singh<br>Title: Executive Vice President & Chief Financial Officer |

---

## Exhibit 99.1

Exhibit 99.1

**HCSG Reports Second Quarter Results**

**Exceeds Growth Expectations** 

**Raises 2025 Cash Flow Forecast**

**Announces $50.0MM Share Repurchase Plan**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Revenue of $458.5 million, an increase of 7.6% over the prior year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income and diluted EPS of ($32.4) million and ($0.44); includes $0.65 non-cash charge related to previously announced Genesis HealthCare restructuring.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash flow from operations of $28.8 million; cash flow from operations (excluding the change in payroll accrual) of $8.5 million, an increase of $10.9 million over the prior year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reiterates 2025 mid-single digit growth expectations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to $85.0 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Announces $50.0 million, 12-month share repurchase plan.

BENSALEM, PA--(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended June 30, 2025.

Ted Wahl, Chief Executive Officer, stated, "Second quarter growth exceeded our expectations. New client wins and higher retention drove our organic growth, and we have carried that positive momentum into the back half of the year. Despite the previously announced Genesis news and resulting impact on our Q2 reported results, our 2025 growth plans and cash flow outlook remain strong. We are confident that continuing to execute on our strategic priorities, supported by our strong business fundamentals, will enable us to further accelerate growth, while delivering sustainable, profitable results."

<u>Second Quarter Results</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue was reported at $458.5 million. Segment revenues for Environmental and Dietary Services were reported at $205.8 million and $252.7 million, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ The Company reiterated its expectation for 2025 mid-single digit revenue growth.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cost of services was reported at $455.5 million or 99.4% and includes the impact of the $61.2 million or 13.4% non-cash charge related to the previously announced Genesis restructuring.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ The Company's goal is to manage the second half of 2025 cost of services in the 86% range.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• SG&A was reported at $49.2 million; after adjusting for the $4.7 million increase in deferred compensation, actual SG&A was $44.5 million or 9.7%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ The Company expects to manage SG&A in the 9.5% to 10.5% range in the near term, with the longer term goal of managing those costs into the 8.5% to 9.5% range.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Segment margin for Environmental Services was reported at 0.8% and includes the impact of a $20.3 million or 9.9% non-cash charge related to the previously announced Genesis restructuring. Segment margin for Dietary Services was reported at (10.1%), and includes the impact of a $40.9 million or 16.2% non-cash charge related to the previously announced Genesis restructuring.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income and diluted EPS were reported at ($32.4) million and ($0.44), respectively, and includes the impact of the $0.65 non-cash charge (or $61.2 million pretax, tax effected at 22.7%) related to the previously announced Genesis restructuring.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ As previously announced, the Company estimates a third quarter $0.04 per share non-cash charge related to the Genesis restructuring.

------

Exhibit 99.1

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash flow from operations was reported at $28.8 million; after adjusting for the $20.3 million increase in the payroll accrual, cash flow from operations was $8.5 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ The Company raised its 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to $85.0 million.

<u>Balance Sheet and Liquidity</u>

The Company's primary sources of liquidity are cash flow from operating activities, cash and cash equivalents, and its revolving credit facility. As of the end of the second quarter, the Company had cash and marketable securities of $164.1 million and a $500.0 million credit facility, inclusive of its $200.0 million accordion, which expires in November 2027.

<u>Share Repurchases</u>

The Company also announced that it plans to accelerate the pace of its share buybacks, and over the next 12 months, intends to repurchase $50.0 million shares of its common stock under its February 2023 share repurchase authorization. The Company repurchased $7.6 million of common stock during the second quarter. Year to date, the Company has repurchased $14.6 million of its common stock.

Mr. Wahl stated, "Over the course of the last several years, we have continuously strengthened our balance sheet and expect strong cash flow generation over the next 12 months and beyond. We have demonstrated a prudent and balanced approach to capital allocation, including first and foremost investing in our growth initiatives. The current valuation of our stock relative to our long-term growth potential offers a unique opportunity with the buyback to return significant capital to shareholders."

<u>Conference Call and Upcoming Events</u>

The Company will host a conference call on Wednesday, July 23, 2025, at 8:30 a.m. Eastern Time to discuss its results for the three months ended June 30, 2025. The call may be accessed via phone at 1 (800) 715-9871, Conference ID: 9951274. The call will be simultaneously webcast under the "Events & Presentations" section of the Investor Relations page on the Company's website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

The Company will be attending and presenting at the Baird 2025 Global Healthcare Conference on September 10, 2025 at the InterContinental Barclay NY.

<u>About Healthcare Services Group, Inc.</u>

Healthcare Services Group (NASDAQ: HCSG) is a leader in managing housekeeping, laundry, dining, and nutritional services within the healthcare industry. With nearly 50 years of experience, HCSG aims to provide improved operational, regulatory, and financial outcomes for our clients.

------

**CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS**

*This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as "believes," "anticipates," "plans," "expects," "estimates," "will," "goal," "intend" and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers' compensation, general liability and auto insurance; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; the impacts of past or future cyber attacks or breaches; global events including ongoing international conflicts; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2024 under "Government Regulation of Customers," "Service Agreements and Collections," and "Competition" and under Item 1A. "Risk Factors" in such Form 10-K.* 

*These factors, in addition to delays in payments from customers and/or customers undergoing restructurings, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results have been in the past and could in the future be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) cannot be passed on to our customers.* 

*In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.*

**USE OF NON-GAAP FINANCIAL INFORMATION**

*To supplement HCSG's consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.*

*The Company is presenting net cash flow from operations (excluding the impact of payroll accrual), earnings before interest, taxes, depreciation and amortization ("EBITDA") and EBITDA excluding items impacting comparability ("Adjusted EBITDA"). We cannot provide a reconciliation of forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.*

---

| |
|:---|
| **Company Contacts:** |
| Theodore Wahl |
| President and Chief Executive Officer |
| Vikas Singh |
| Executive Vice President and Chief Financial Officer |
| Matthew J. McKee |
| Chief Communications Officer |
| 215-639-4274 |
| investor-relations@hcsgcorp.com |

---

------

**HEALTHCARE SERVICES GROUP, INC.**

**CONSOLIDATED STATEMENTS OF (LOSS) INCOME**

**(Unaudited)**

**(in thousands, except per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended** | **For the Three Months Ended** | **For the Six Months Ended** | **For the Six Months Ended** |
| | **June 30,** | **June 30,** | **June 30,** | **June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Revenue | $458491 | $426288 | $906153 | $849721 |
| Operating costs and expenses: |  |  |  |  |
| &nbsp;&nbsp;Cost of services | 455533 | 384742 | 835224 | 743653 |
| &nbsp;&nbsp;Selling, general and administrative | 49163 | 44437 | 94129 | 91348 |
| (Loss) income from operations | (46205) | (2891) | (23200) | 14720 |
| Other income, net | 4317 | 905 | 5206 | 4608 |
| (Loss) income before income taxes | (41888) | (1986) | (17994) | 19328 |
| Income tax (benefit) provision | (9522) | (198) | (2856) | 5807 |
| Net (loss) income | $(32366) | $(1788) | $(15138) | $13521 |
| Basic (loss) income per share | $(0.44) | $(0.02) | $(0.21) | $0.18 |
| Diluted (loss) income per common share | $(0.44) | $(0.02) | $(0.21) | $0.18 |
| Basic weighted average number of common shares outstanding | 73161 | 73853 | 73414 | 73889 |
| Diluted weighted average number of common shares outstanding | 73161 | 73853 | 73414 | 74048 |

---

------

**HEALTHCARE SERVICES GROUP, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(Unaudited)**

**(in thousands)**

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 31, 2024** |
| Cash and cash equivalents | $82818 | $56776 |
| Restricted cash equivalents | 326 | 3355 |
| Marketable securities, at fair value | 51674 | 50535 |
| Restricted marketable securities, at fair value | 29258 | 25105 |
| Accounts receivable, net | 292210 | 330907 |
| Notes receivable — short-term, net | 31628 | 51429 |
| Other current assets | 44380 | 38545 |
| &nbsp;&nbsp;Total current assets | 532294 | 556652 |
| Property and equipment, net | 28215 | 28198 |
| Notes receivable — long-term, net | 45084 | 41054 |
| Goodwill | 80042 | 75529 |
| Other intangible assets, net | 8263 | 9442 |
| Deferred compensation funding | 51548 | 49639 |
| Other assets | 56754 | 42258 |
| Total assets | $802200 | $802772 |
| Accrued insurance claims — current | $24578 | $25148 |
| Other current liabilities | 189354 | 167399 |
| &nbsp;&nbsp;Total current liabilities | 213932 | 192547 |
| Accrued insurance claims — long-term | 50833 | 51869 |
| Deferred compensation liability — long-term | 51699 | 50011 |
| Lease liability — long-term | 7048 | 8033 |
| Other long-term liabilities | 1650 | 385 |
| Stockholders' equity | 477038 | 499927 |
| Total liabilities and stockholders' equity | $802200 | $802772 |

---

------

**HEALTHCARE SERVICES GROUP, INC.**

**RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES** 

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Reconciliation of GAAP net (loss) income to EBITDA and adjusted EBITDA (in thousands)*** | **For the Three Months Ended** | **For the Three Months Ended** | **For the Six Months Ended** | **For the Six Months Ended** |
| ***Reconciliation of GAAP net (loss) income to EBITDA and adjusted EBITDA (in thousands)*** | **June 30,** | **June 30,** | **June 30,** | **June 30,** |
| ***Reconciliation of GAAP net (loss) income to EBITDA and adjusted EBITDA (in thousands)*** | **2025** | **2024** | **2025** | **2024** |
| **GAAP net (loss) income** | $(32366) | $(1788) | $(15138) | $13521 |
| &nbsp;&nbsp;Income tax (benefit) provision | (9522) | (198) | (2856) | 5807 |
| &nbsp;&nbsp;Interest, net | (1976) | 184 | (4186) | 138 |
| &nbsp;&nbsp;Depreciation and amortization<sup>(1)</sup> | 5001 | 3679 | 8879 | 7210 |
| **EBITDA** | $(38863) | $1877 | $(13301) | $26676 |
| &nbsp;&nbsp;Share-based compensation | 2541 | 2113 | 6279 | 4597 |
| **Adjusted EBITDA** | $(36322) | $3990 | $(7022) | $31273 |
| &nbsp;&nbsp;*Adjusted EBITDA as a percentage of revenue* | *(7.9) %* | *0.9 %* | *(0.8) %* | *3.7 %* |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Reconciliation of GAAP cash flows provided by (used in) operations to net cash flows from operations (excluding the change in payroll accrual)*** | **For the Three Months Ended** | **For the Three Months Ended** | **For the Six Months Ended** | **For the Six Months Ended** |
| ***Reconciliation of GAAP cash flows provided by (used in) operations to net cash flows from operations (excluding the change in payroll accrual)*** | **June 30,** | **June 30,** | **June 30,** | **June 30,** |
| ***Reconciliation of GAAP cash flows provided by (used in) operations to net cash flows from operations (excluding the change in payroll accrual)*** | **2025** | **2024** | **2025** | **2024** |
| **GAAP cash flows provided by (used in) operations** | $28787 | $16319 | $56288 | $(9714) |
| &nbsp;&nbsp;Accrued payroll<sup>(2)</sup> | (20256) | (18677) | (15665) | (1862) |
| **Cash flows from operations (excluding the change in payroll accrual)** | $8531 | $(2358) | $40623 | $(11576) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Includes right-of-use asset depreciation of $2.1 million and $4.2 million for the three and six months ended June 30, 2025, and $2.0 million and $3.8 million for the three and six months ended June 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The accrued payroll adjustment reflects changes in accrued payroll for the three and six months ended June 30, 2025 and 2024. The Company processes payroll on set weekly and bi-weekly schedules, and the timing of payments may result in operating cash flow increases or decreases which are not indicative of the Company's quarterly cash flow performance.